| Literature DB >> 31083232 |
Seung-Ho Lee1,2, Sun-Mi Hwang3, Do-Hyung Kang4, Hyun-Jeong Yang1,5,6.
Abstract
BACKGROUND: Hypertension and type 2 diabetes are chronic diseases, which generally require lifetime care. Meditation and yoga can be complementary to pharmacological therapies according to the scientific evidences so far. Brain education-based meditation (BEM) is a technique, which has been known to change brain structure, psychology, and physiology of healthy adult participants. This randomized, nonblinded pilot trial aimed to examine whether BEM affects the conditions of patients with hypertension and/or type 2 diabetes compared with health education classes.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31083232 PMCID: PMC6531095 DOI: 10.1097/MD.0000000000015574
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Baseline characteristics of sex/disease/age-matched participants for inflammatory gene expression analysis.
Pre and post mean, SD, t tests for self-reports and blood tests of participants of inflammatory gene expression analysis.
Pre and post mean, SD, t tests for physical health score.
Pre and post mean, SD, t tests for mental health scores.
Baseline characteristics of randomized participants.
Pre and post mean, SD, t test for self-reports and blood tests.
Figure 1Alterations in values of self-reports and blood markers between preintervention and postintervention. “BEM (Att ≥ 5)” presents brain education-based meditation (BEM) group with high attendance rate: more than 5 times of attendance. The indicated values stand for the subtraction of values at preintervention from values at postintervention. Dots at the midline (y = 0) mean no changes between the values of preintervention and postintervention. The values of following self-reports and blood markers are shown: (A) mental health; (B) physical health; (C) serum glutamic-oxaloacetic transaminase (SGOT); (D) serum glutamic pyruvic transaminase (SGPT); (E) γ-glutamyl transferase (GGT); (F) creatinine; (G) high-density lipoprotein (HDL) cholesterol; (H) low-density lipoprotein (LDL) cholesterol. ∗P = .04, an independent samples t test between BEM (Att ≥ 5) and control; ∗P = .01, an independent samples t test between BEM and control; #P = .04, a paired samples t test from the same group at preintervention and postintervention; n = 8 (BEM (Att ≥ 5)), 21 (BEM), and 14 (control). Dots and error bars indicate the mean values and standard of errors, respectively. Att = attendance, GGT = γ-Glutamyl transferase, HDL = high-density lipoprotein, LDL = low-density lipoprotein, SGOT = serum glutamic-oxaloacetic transaminase, SGPT = serum glutamic pyruvic transaminase.
Figure 2Relative inflammatory gene expressions of the meditation group at preintervention and postintervention. Expression of inflammatory genes was all initially normalized by ACTB expression and the normalized values were used for further analysis. Second normalizations for values of brain education-based meditation (BEM) group at preintervention and postintervention were done by using values of control group of the same time point; this was performed due to the gene expression changes by the temperature at preintervention and postintervention. Dots indicate the mean values of the following relative gene expressions of BEM group, which are normalized by the value of the control group: (A) Nuclear Factor kappa B subunit 2 (NF-κB2), ∗P = .01; (B) RELA, ∗P = .03; (C) RELB, P = .34; (D) interleukin 1 beta (IL1B), ∗∗P < .01, a paired samples t test (n = 6 and 8 for control and BEM, respectively). Error bars indicate standard of errors.